Healthy Volunteers — Influence of Scaler Tip Design on Patients' Pain Perception
Citation(s)
Berggren U, Meynert G Dental fear and avoidance: causes, symptoms, and consequences. J Am Dent Assoc. 1984 Aug;109(2):247-51.
Jepsen S, Ayna M, Hedderich J, Eberhard J Significant influence of scaler tip design on root substance loss resulting from ultrasonic scaling: a laserprofilometric in vitro study. J Clin Periodontol. 2004 Nov;31(11):1003-6.
Kawashima H, Sato S, Kishida M, Ito K A comparison of root surface instrumentation using two piezoelectric ultrasonic scalers and a hand scaler in vivo. J Periodontal Res. 2007 Feb;42(1):90-5.
Lea SC, Landini G, Walmsley AD Displacement amplitude of ultrasonic scaler inserts. J Clin Periodontol. 2003 Jun;30(6):505-10.
Lea SC, Landini G, Walmsley AD The effect of wear on ultrasonic scaler tip displacement amplitude. J Clin Periodontol. 2006 Jan;33(1):37-41.
Lea SC, Landini G, Walmsley AD Ultrasonic scaler tip performance under various load conditions. J Clin Periodontol. 2003 Oct;30(10):876-81.
von Troil B, Needleman I, Sanz M A systematic review of the prevalence of root sensitivity following periodontal therapy. J Clin Periodontol. 2002;29 Suppl 3:173-7; discussion 195-6. Review.
Influence of Scaler Tip Design on Patients' Pain Perception
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
